Rare cancer registry launches to unlock secrets of MLA
NCT ID NCT06377527
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study aims to create a database of medical information from up to 2,000 people with mesonephric-like adenocarcinoma (MLA), a very rare form of uterine cancer. Researchers will collect data to better understand the disease's characteristics and behavior. No treatments or tests are given—participants simply allow their existing medical records to be used for research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESONEPHRIC-LIKE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.